Overview
Steven Gore, MD, earned his undergraduate and doctoral degrees at Yale, performed his residency at the University of Chicago and his oncology fellowship at Johns Hopkins. He rose from instructor to full professor at Johns Hopkins, and, in 2013, he became professor of medicine and director of hematologic malignancies at Yale.
Dr. Gore is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Tissue Biopsy.
His clinical research consists of co-authoring 220 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
9609 Medical Center Dr, Rockville, MD 20850
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Regional Cancer Care Associates LLC
James Mccloskey is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Mccloskey is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Colonoscopy.
Scott Rowley is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Rowley is rated as an Elite provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Colonoscopy.
Johns Hopkins University
Mark Levis is an Oncologist in Bethesda, Maryland. Dr. Levis is rated as an Elite provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Distinguished
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Chronic Myelomonocytic Leukemia (CMML)Dr. Gore isDistinguished. Learn about Chronic Myelomonocytic Leukemia (CMML).
- LeukemiaDr. Gore isDistinguished. Learn about Leukemia.
- Advanced
- Acute Myelomonocytic LeukemiaDr. Gore isAdvanced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Gore isAdvanced. Learn about Acute Promyelocytic Leukemia.
- Childhood Acute Myeloid Leukemia
- Hairy Cell Leukemia (HCL)Dr. Gore isAdvanced. Learn about Hairy Cell Leukemia (HCL).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Gore isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- AgranulocytosisDr. Gore isExperienced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Gore isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Gore isExperienced. Learn about Bone Marrow Aspiration.
- Castleman DiseaseDr. Gore isExperienced. Learn about Castleman Disease.
- Chronic B-Cell Leukemia (CBCL)Dr. Gore isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).